Cegedim acquires French medical data expert Clinityx,

Cegedim acquires French medical data expert Clinityx, strengthening its place in Real-World-Data

Boulogne-Billancourt, France, October 20, 2022

Cegedim, the modern expertise, providers, and well being data firm, publicizes the acquisition of Clinityx, an innovator in unlocking the complete potential of well being data in France. This addition to the portfolio of THIN^®-driven Real-World Data and Real-World Evidence options headed by the Cegedim Health Data division, furthers Cegedim’s ambition of turning into Europe’s real-world well being data chief.

Clinityx makes a speciality of modern methods to unlock the complete potential of well being data and boasts distinctive experience in real-world data, notably in secured well being data warehouses and linking them with the SNDS (the French administrative healthcare database).
Clinityx companions with scientific societies, hospitals, and cooperative teams to construct secured data warehouses which can be natively linked with the SNDS and is collectively liable for processing their data. Through these data warehouses, it facilitates entry to analysis cohorts and registries enriched with administrative well being data. Clinityx boasts distinctive expertise in secured data warehouses, having deployed 5 which can be accredited by CNIL, France’s data safety authority. They are Magellan, CardioHub (cardiology), UroCCR Chain (kidney most cancers), Colibri (pulmonology), and DataMesh (gynecology).
Clinityx’s improvements intention to supply wider, simpler, faster entry to SNDS data, and larger transparency for sufferers.

Clinityx can be a consultancy agency, advising pharma and medtech corporations on how one can implement real-world-evidence tasks for exploratory analysis and for well being authorities.

Clinityx has joined forces with the Cegedim Group—which acquired a majority stake within the start-up in July 2022— to make sure its continued development and innovation.

David Syr, Deputy Managing Director of GERS Data, the French division of Cegedim’s data business, commented: “With its unique blend of regulatory and technological know-how, Clinityx boosts our real-world data offering and expands the scope of possible applications. It will enable us to reduce the set-up time of studies using these types of data sources for all healthcare stakeholders —pharma companies, research organizations, academic institutions, and health authorities—both in France and Europe, and thus better serve the interests of public health.”

Nicolas Glatt, CEO of Clinityx commented: “We are very happy to be part of the Cegedim Group, which will help us accelerate our expansion in France and internationally. Our know-how in administrative health databases rounds out the THIN^®️ real-world data and GERS Data drug consumption data offerings.”

• Cegedim_Clinityx_20102022_ENG